--- title: "Select 医药控股、Unifirst、Centessa Pharmaceuticals 和 Assertio 是否为其股东争取到了公平的交易？" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/286972902.md" description: "Halper Sadeh LLC 正在调查 Select Medical Holdings、UniFirst Corporation、Centessa Pharmaceuticals 和 Assertio Holdings 是否存在潜在的联邦证券法违规行为和违反信托责任的情况。该公司呼吁股东讨论他们关于近期销售的权利，并可能代表他们寻求增加补偿或额外披露" datetime: "2026-05-19T22:24:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286972902.md) - [en](https://longbridge.com/en/news/286972902.md) - [zh-HK](https://longbridge.com/zh-HK/news/286972902.md) --- # Select 医药控股、Unifirst、Centessa Pharmaceuticals 和 Assertio 是否为其股东争取到了公平的交易？ **_Insiders may stand to receive substantial financial benefits not available to ordinary shareholders._** **_The proposed transactions may contain terms that could limit superior competing offers._** **_Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses._** NEW YORK, May 19, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: **Select Medical Holdings Corporation ()'s** sale to a consortium led by Select Medical executives and directors for $16.50 in cash per share. **If you are a Select Medical shareholder,** **click here to learn more about your rights and options****.** **UniFirst Corporation ()'s** sale to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share. **If you are a UniFirst shareholder,** **click here to learn more about your rights and options****.** **Centessa Pharmaceuticals plc ()'s** sale to Eli Lilly and Company for $38.00 in cash per share plus one non-transferrable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones. **If you are a Centessa shareholder,** **click here to learn more about your legal rights and options**. **Assertio Holdings, Inc. ()'s** sale to Garda Therapeutics for $18.00 per share in cash and a contingent value right. **If you are an Assertio shareholder,** **click here to learn more about your legal rights and options**. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com https://www.halpersadeh.com SOURCE Halper Sadeh LLP ### 相关股票 - [CNTA.US](https://longbridge.com/zh-CN/quote/CNTA.US.md) - [UNF.US](https://longbridge.com/zh-CN/quote/UNF.US.md) - [ASRT.US](https://longbridge.com/zh-CN/quote/ASRT.US.md) - [SEM.US](https://longbridge.com/zh-CN/quote/SEM.US.md) - [CTAS.US](https://longbridge.com/zh-CN/quote/CTAS.US.md) - [LLY.US](https://longbridge.com/zh-CN/quote/LLY.US.md) ## 相关资讯与研究 - [Assertio 投资者警示：Kahn Swick & Foti, LLC 正在调查拟议出售 Assertio Holdings, Inc. - ASRT 的价格和流程是否合理](https://longbridge.com/zh-CN/news/286953224.md) - [Unifirst 投资者警报：Kahn Swick & Foti, LLC 正在调查拟议出售 Unifirst Corporation - UNF 的价格和流程是否合理](https://longbridge.com/zh-CN/news/286950621.md) - [分析 Select 医药控股（SEM）的估值，因其近期表现和模型传递出不同的信号](https://longbridge.com/zh-CN/news/286863175.md) - [06:58 ET Unifirst 推出 Essential Series™：全面的洗手间解决方案](https://longbridge.com/zh-CN/news/286899251.md) - [Unifirst｜8-K：2026 财年 Q2 营收 6.23 亿美元超过预期](https://longbridge.com/zh-CN/news/281363355.md)